文献速递系统性红斑狼疮

CCR2与CCR5介导的巨噬细胞浸润参与抗体诱导的狼疮肾炎肾小球内皮细胞增生

CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究在小鼠模型中探讨巨噬细胞趋化因子受体在狼疮肾炎肾小球病变中的作用,发现CCR2和CCR5调控肾小球巨噬细胞浸润并促进内皮细胞增生,而CCR5拮抗剂maraviroc可减轻该病变且不诱导wire-loop病变。

要点

  • 2B11.3抗体诱导的肾小球内皮细胞增生伴随CD68阳性巨噬细胞浸润及CCL2、CCL3、CCR2、CCR5、CX3CR1表达增强。
  • CCR2-/-和CCR5-/-小鼠内皮细胞增生减轻、巨噬细胞浸润减少、血尿素氮改善,而CX3CR1-/-小鼠无此效应。
  • CCR5拮抗剂maraviroc减轻2B11.3诱导的内皮细胞增生并改善血尿素氮水平。

核心结论

  • CCR2和CCR5调控肾小球巨噬细胞浸润,并参与狼疮肾炎肾小球内皮细胞增生的发生。
  • CCR5抑制可作为针对内皮细胞增生的特异性治疗,且不诱导wire-loop病变。

研究设计与样本

  • 将MRL/lpr小鼠来源的单克隆IgG3抗体杂交瘤2B11.3和B1分别腹腔注射至BALB/c野生型小鼠,以分别诱导内皮细胞增生和wire-loop病变。
  • 采用实时定量PCR和免疫荧光分析趋化因子及趋化因子受体表达,并利用趋化因子受体缺陷小鼠或选择性CCR5拮抗剂maraviroc评估受体作用。

主要发现

  • 2B11.3诱导肾小球内皮细胞增生伴显著肾小球CD68阳性巨噬细胞浸润,且肾皮质CCL2、CCL3、CCR2、CCR5和CX3CR1表达较B1注射增强。
  • 2B11.3诱导的病变中,肾小球CD68阳性巨噬细胞表达CCL2、CCL3、CCR2、CCR5和CX3CR1,肾小球内皮细胞表达CCL2、CCL3、CX3CL1和CCR2。
  • 注射2B11.3后,CCR2-/-和CCR5-/-小鼠内皮细胞增生减轻、肾小球巨噬细胞浸润减少、血清血尿素氮水平改善,而CX3CR1-/-小鼠无上述改变。
  • 仅CCR2-/-小鼠出现wire-loop病变;B1注射在趋化因子受体缺陷小鼠中诱导的wire-loop病变程度与野生型相似。
  • maraviroc治疗减轻2B11.3诱导的内皮细胞增生并改善血清血尿素氮水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: LN comprises various glomerular lesions, including endocapillary hypercellularity with macrophage infiltration. In this study, we aimed to clarify the involvement of macrophage-tropic chemokine receptors in the pathogenesis of these glomerular lesions. METHODS: MRL/lpr mouse-derived monoclonal IgG3 antibody-producing hybridomas, 2B11.3 and B1, were injected intraperitoneally into BALB/c mice [wild type (WT)] to induce endocapillary hypercellularity and wire-loop lesions, respectively. The expression of chemokine and chemokine receptors was analysed by quantitative real-time PCR and IF. The roles of chemokine receptors in these lesions were evaluated using chemokine receptor-deficient mice or a selective CCR5 antagonist, maraviroc. RESULTS: 2B11.3 caused glomerular endocapillary hypercellularity with a significant number of glomerular CD68-positive macrophages. Further, enhanced expression of CCL2, CCL3, CCR2, CCR5 and CX3CR1 was observed in the renal cortex, compared with B1 injection, which induced wire-loop lesions. In 2B11.3-induced glomerular lesions, CD68 -positive glomerular macrophages expressed CCL2, CCL3, CCR2, CCR5 and CX3CR1, while glomerular endothelial cells expressed CCL2, CCL3, CX3CL1 and CCR2. When 2B11.3 was injected, CCR2-/- and CCR5-/-, but not CX3CR1-/-, mice exhibited reduced endocapillary hypercellularity, attenuated glomerular macrophage infiltration and improved serum blood urea nitrogen levels. Only CCR2-/- mice developed wire-loop lesions. B1 injection caused wire-loop lesions in these chemokine receptor-deficient mice to a similar extent as WT. Maraviroc treatment reduced 2B11.3-induced endocapillary hypercellularity and improved serum blood urea nitrogen levels. CONCLUSION: CCR2 and CCR5 regulate glomerular macrophage infiltration and contribute to the development of glomerular endocapillary hypercellularity in LN. CCR5 inhibition can be a specific therapy for endocapillary hypercellularity without inducing wire-loop lesions.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zoshima T, Baba T, Tanabe Y, et al. CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis. Rheumatology (Oxford). 2022. PMID: 34747459. doi:10.1093/rheumatology/keab825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。